- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03252418
Ascorbic Acid Versus Diode Laser in the Treatment of Gingival Hyperpigmentation
Ascorbic Acid Versus Diode Laser in the Treatment of Gingival Hyperpigmentation: Histological and Clinical Randomized Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cosmetic dentistry is usually centered on aesthetic restorative procedures but it may also involve the appearance of the gingiva, especially when it is located in the anterior labial region. Oral pigmentation may be physiological or pathological in nature. Better esthetics results of depigmentation were achieved with diode laser than conventional scalpel and with rotary abrasion, also diode laser is effective and safe in removal of gingival hyperpigmentation and repigmentation doesn't occur.When choosing a depigmenting agent, it is important to differentiate between substances that are toxic to the melanocyte and substances that interrupt the key steps of melanogenesis. Vit. C interacts with copper ions at the tyrosinase-active site and inhibits action of the enzyme tyrosinase, thereby decreasing the melanin formation.
This randomized comparative clinical study was conducted on ten patients attending the outpatient clinic of the Oral Medicine and Periodontology department, Faculty of Dentistry, Ain Shams University and seeking treatment for their gingival hyperpigmentation for esthetic reason.
The study was conducted after receiving an ethical clearance from the Research Ethics Committee of Ain Shams University, Faculty of Dentistry; that the study follows the ethical guidelines of research. The patients clearly understood the purpose of this study and signed an informed consent.
According to the study results, vit C treated patients showed no or little repigmentation after six months post treatment. Conversely, diode laser treated patients showed significant recurrence of gingival pigmentation after six months post treatment. These could be attributed to the blocking effect of vitamin C on the existing melanocytes to form new melanoseomes, however diode laser cause removal of the existing melanocytes that may cause formation of new melanocytes (migrating from neighboring melanocytes from the adjacent area of the gingiva) with the ability of forming new melanosomes and causing repigmentation. Histopathological assessment revealed that both treatment modalities caused significant reduction in MAF after six months post treatment.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and female patients with age ranging from 18 years old to 40 years old.
- Bilaterally symmetric gingival hyperpigmentation on the maxillary and mandibular labial keratinized gingiva between canines.
- Patients free from any systemic diseases as evidenced by the health questionnaire, using modified Cornell medical index (Pendleton et al., 2004).
- Patients with thick gingival biotype ≥ 3 mm.
Exclusion Criteria:
- Presence of local condition that may cause gingival hyperpigmentation (traumatized epithelium caused by defective fixed prosthesis or restoration).
- Smokers.
- Pregnant or lactating females.
- Patients with poor oral hygiene, incompliance to treatment and persistence gingival inflammation after phase I periodontal therapy.
- Clinically diagnosed periodontitis (attachment and bone loss, presence of periodontal pockets, gingival recession and tooth mobility).
- Previous treatment to pigmentation.
- Patients taking supplementary vitamin C for any reason.
- Known sensitivity to ascorbic acid or any of its derivatives.
- Patients taking any drug that may cause gingival pigmentation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: ascorbic acid
injection of 1 ml intamucosal ascorbic acid 3 times with 1 week interval
|
ascorbic acid is vitamin that can cause gingival depigmentation
|
EXPERIMENTAL: diode laser
photothermolysis by diode laser in one session
|
diode laser is soft tissue laser case photothermolysis of melanoctes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dummett oral pigmentaion index (DOPI)
Time Frame: change from baseline to 1, 3 and 6 months
|
scoring from 0 ( no pigmentation to 3 (sever pigmentation
|
change from baseline to 1, 3 and 6 months
|
gingival brightness (ΔL)
Time Frame: change from baseline to 1, 3 and 6 months
|
using spectrophotometer
|
change from baseline to 1, 3 and 6 months
|
histological mean area fraction of melanosomes
Time Frame: change from baseline to 6 months
|
by taking soft tissue samples and stained by fontana masson stain
|
change from baseline to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
patient satisfaction questionnaire
Time Frame: immediate postopearive, 1 week, 1 month and 6 months
|
from scoring patients pain and cosmetic changes
|
immediate postopearive, 1 week, 1 month and 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Nevine H kheir ElDien, Professor, faculty of Dentistry- Ain Shams univesity
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FDASU-RECIM10201512
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingival Hyperpigmentaion
-
Tokat Gaziosmanpasa UniversityCompletedGingival Recession | Gingival EnlargementTurkey
-
Tokat Gaziosmanpasa UniversityCompletedGingival EnlargementTurkey
-
Cairo UniversityUnknownGingival Thickness | Gingival Biotype | Periodontal Probe
-
Alexandria UniversityCompletedGingival EnlargementEgypt
-
University of BaghdadRecruitingThickening; GingivalIraq
-
Tokat Gaziosmanpasa UniversityCompleted
-
The University of Hong KongUnknown
-
University of Padova, School of Dental MedicineCompletedGingival Recession | Gingival Bleeding | Gingival DiseaseItaly
-
Semmelweis UniversityRecruitingRecurrence | Periodontal; Lesion | Localized Gingival Enlargement | EpulidesHungary
-
Inonu UniversityCompletedWound Heal | Gingival Enlargement | Gingival Overgrowth | Platelet Rich FibrinTurkey
Clinical Trials on Ascorbic Acid 500 MG
-
Swiss Federal Institute of TechnologyCompletedIron-deficiency | Iron Deficiency AnemiaSwitzerland
-
University of North Carolina, Chapel HillNational Institute of Nursing Research (NINR); Sigma Theta Tau International...Completed
-
Instituto Nacional de Perinatologia Isidro Espinosa...Active, not recruitingInsulin Resistance | PostmenopausalMexico
-
National Taiwan University Hospital Hsin-Chu BranchCompletedHemodialysis Access Failure
-
Fundacion para la Formacion e Investigacion Sanitarias...Completed
-
Mahidol UniversityUnknownPeriodontitis | Diabetes Mellitus Type 2 With HyperglycemiaThailand
-
McGuff Pharmaceuticals, Inc.Completed
-
Christian Medical College and Hospital, Ludhiana...All India Institute of Medical Sciences, New Delhi; Indian Council of Medical... and other collaboratorsRecruitingIntracerebral Hemorrhagic StrokeIndia
-
Desitin Arzneimittel GmbHBioPharma Services, IncCompleted
-
Helwan UniversityActive, not recruitingPost Operative Atrial FibrillationEgypt